Novo Nordisk Faces Challenges After Missing Profit Expectations

The Danish pharmaceutical giant Novo Nordisk reports somewhat below the analysts' expectations. The company states that it will present measures, but according to analysts, it still has no answer to how the challenges will be addressed. If they had an answer, the share would have soared, but it doesn't, says Per Hansen, savings economist at Nordnet in Denmark.